New standards for AI clinical trials will help spot snake oil and hype

The news: An international consortium of medical experts has introduced the first official standards for clinical trials that involve artificial intelligence. The move comes at a time when hype around medical AI is at a peak, with inflated and unverified claims about the effectiveness of certain tools threatening to undermine people’s trust in AI overall. 

What it means: Announced in Nature Medicine, the British Medical Journal, and the Lancet, the new standards extend two sets of guidelines around how clinical trials are conducted and reported that are already used around the world for drug development, diagnostic tests, and

Read More